Dollars

SPDR S&P Biotech ETF receives settlement payment

Wed, 20/08/2014 - 06:01

State Street Global Advisors’ SPDR S&P Biotech ETF has received a payment as an authorised claimant from a class action settlement related to Dendreon Corp.

The total amount payable to the fund is USD233,312.
 
When the fund calculates its net asset value (NAV) per share on 19 August it is estimated that the fund’s NAV will be impacted by USD0.0311 for each of the existing 7,500,000 shares.


Subscribe to free daily newsletter
Furtherreading
from our other sites

Cayman Islands funds

Fri 19/12/2014 - 11:23

latestjobs
Quantitative Trading Strategist | Front Office

Sat, 20 Dec 2014 00:00:00 GMT

Entry Level Financial Software Developer

Sat, 20 Dec 2014 00:00:00 GMT

C#.NET Developer – Quantitative Risk, Fixed Income

Sat, 20 Dec 2014 00:00:00 GMT

events
3 weeks 1 day from now - New Orleans
4 weeks 3 days from now - Boston
4 weeks 3 days from now - New York
5 weeks 6 hours from now - New York
specialreports